Trade/Invest with Options Jerry a Point & Figure Chartist Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Trade/Invest with Options Jerry a Point & Figure Chartist

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Jerry Olson who wrote (5127)	2/21/2002 8:50:44 AM
From: SusieQ1065	Read Replies (1) of 5893

PRU downgraded it to sell, Jer...along with MLNM & CRA. ET MYGN Myriad Genetics started with SELL at Pru (38.99) Stock trades down 6% in pre-market to $36.50 after Prudential initiates coverage of stock with a SELL rating and $25 price target. The comment is part of a sector call on the genomics sector that also included initiation of CRA and MLNM with Buy ratings. With respect to MYGN, firm cites significant commercial, collaborative and clinical risk in coming qtrs. Does not believe MYGN's genetic tests add substantially to the treatment decision, and thus may not be the high growth products investors may anticipate.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next